Free alerts

GRCE insider buying

Every open-market purchase of Grace Therapeutics, Inc. (GRCE) stock by its officers, directors and major shareholders, from SEC Form 4 filings.

Bought, last 12 months$766.56K
Insiders buying (12m)2
Purchases on record9
Last purchase filedOct 26, 2026

In the last 12 months, 2 insiders of Grace Therapeutics, Inc. bought $766.56K of GRCE stock on the open market in 9 reported purchases. The most recent was filed on Oct 26, 2026: Opaleye Management Inc. (10% Owner) bought 87,801 shares at $1.81, worth $158.60K. The largest purchase on record here is $214K by Kohli Prashant on Sep 9, 2026.

Get the next GRCE insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.

Join free on Telegram

All GRCE insider purchases

FiledInsiderValueSharesPriceStakeTrade
Oct 26Opaleye Management Inc.10% Owner$158.60K87,801$1.81+3%Oct 22SEC
Oct 16Opaleye Management Inc.10% Owner$136.18K71,065$1.92+2%Oct 14SEC
Oct 13Opaleye Management Inc.10% Owner$29.68K14,632$2.03+0%Oct 8SEC
Oct 5Opaleye Management Inc.10% Owner$123.82K60,490$2.05+2%Oct 1SEC
Oct 1Opaleye Management Inc.10% Owner$16.40K7,849$2.09+0%Sep 29SEC
Sep 23Opaleye Management Inc.10% Owner$31.69K15,089$2.10+0%Sep 21SEC
Sep 10Opaleye Management Inc.10% Owner$31.92K15,229$2.10+1%Sep 8SEC
Sep 10Kohli PrashantChief Executive Officer, Director$214K100,000$2.14+468%Sep 9SEC
Aug 19Opaleye Management Inc.10% Owner$24.26K11,608$2.09+0%Aug 14SEC